Literature DB >> 32815604

Online Clinical Consensus Diagnosis of Dementia: Development and Validation.

Jinkook Lee1,2, Mary Ganguli3, Albert Weerman1, Sandy Chien1, Dong Young Lee4, Mathew Varghese5, Aparajit B Dey6.   

Abstract

OBJECTIVES: To introduce cost-effective expert clinical diagnoses of dementia into population-based research using an online platform and to demonstrate their validity against in-person clinical assessment and diagnosis.
DESIGN: The online platform provides standardized data necessary for clinicians to rate participants on the Clinical Dementia Rating (CDR® ). Using this platform, clinicians diagnosed 60 patients at a range of CDR levels at two clinical sites. The online consensus diagnosis was compared with in-person clinical consensus diagnosis.
SETTING: All India Institute of Medical Sciences (AIIMS), Delhi, and National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. PARTICIPANTS: Thirty patients each at AIIMS and NIMHANS with equal numbers of patients previously independently rated in person by experts as CDR is 0 (cognitively normal), CDR is 0.5 (mild cognitive impairment), and CDR is 1 or greater (dementia). MEASUREMENTS: Multiple clinicians independently rate each participant on each CDR domain using standardized data and expert clinical judgment. The overall summary CDR is calculated by algorithm. When there are discrepancies among clinician ratings, clinicians discuss the case through a virtual consensus conference and arrive at a consensus overall rating.
RESULTS: Online clinical consensus diagnosis based on standardized interview data provides consistent clinical diagnosis with in-person clinical assessment and consensus diagnosis (κ coefficient = 0.76).
CONCLUSION: A web-based clinical consensus platform built on the Harmonized Diagnostic Assessment of Dementia for the Longitudinal Aging Study in India interview data is a cost-effective way to obtain reliable expert clinical judgments. A similar approach can be used for other epidemiological studies of dementia. J Am Geriatr Soc 68:S54-S59, 2020.
© 2020 The American Geriatrics Society.

Entities:  

Keywords:  Clinical Dementia Rating; Harmonized Cognitive Assessment Protocol; Longitudinal Aging Study in India; clinical judgment; population-based research

Mesh:

Year:  2020        PMID: 32815604      PMCID: PMC7513553          DOI: 10.1111/jgs.16736

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  11 in total

1.  Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.

Authors:  Donald R Royall; Raymond F Palmer; Teruyuki Matsuoka; Yuka Kato; Shogo Taniguchi; Mayu Ogawa; Hiroshi Fujimoto; Aiko Okamura; Keisuke Shibata; Kaeko Nakamura; Shutaro Nakaaki; Hiroyuki Koumi; Masaru Mimura; Kenji Fukui; Jin Narumoto
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  The δ latent dementia phenotype in the uniform data set: Cross-validation and extension.

Authors:  Brandon E Gavett; Vanessa Vudy; Mary Jeffrey; Samantha E John; Ashita S Gurnani; Jason W Adams
Journal:  Neuropsychology       Date:  2014-08-25       Impact factor: 3.295

Review 3.  India's demographic change: opportunities and challenges.

Authors:  K S James
Journal:  Science       Date:  2011-07-29       Impact factor: 47.728

4.  Cross-validation of brain structural biomarkers and cognitive aging in a community-based study.

Authors:  James T Becker; Ranjan Duara; Ching-Wen Lee; Leonid Teverovsky; Beth E Snitz; Chung-Chou H Chang; Mary Ganguli
Journal:  Int Psychogeriatr       Date:  2012-03-16       Impact factor: 3.878

5.  The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.

Authors:  Samantha E John; Ashita S Gurnani; Cara Bussell; Jessica L Saurman; Jason W Griffin; Brandon E Gavett
Journal:  Neuropsychology       Date:  2016-11       Impact factor: 3.295

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1.

Authors:  David R Weir; Robert B Wallace; Kenneth M Langa; Brenda L Plassman; Robert S Wilson; David A Bennett; Ranjan Duara; David Loewenstein; Mary Ganguli; Mary Sano
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

8.  Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort.

Authors:  Donald R Royall; Raymond F Palmer; Kyriakos S Markides
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2017-10-01       Impact factor: 4.077

9.  A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.

Authors:  Alden L Gross; Jason J Hassenstab; Sterling C Johnson; Lindsay R Clark; Susan M Resnick; Melissa Kitner-Triolo; Colin L Masters; Paul Maruff; John C Morris; Anja Soldan; Corinne Pettigrew; Marilyn S Albert
Journal:  Alzheimers Dement (Amst)       Date:  2017-05-30

10.  LASI-DAD study: a protocol for a prospective cohort study of late-life cognition and dementia in India.

Authors:  Jinkook Lee; Joyita Banerjee; Pranali Yogiraj Khobragade; Marco Angrisani; A B Dey
Journal:  BMJ Open       Date:  2019-07-31       Impact factor: 2.692

View more
  2 in total

1.  Introduction to LASI-DAD: The Longitudinal Aging Study in India-Diagnostic Assessment of Dementia.

Authors:  Jinkook Lee; Aparajit B Dey
Journal:  J Am Geriatr Soc       Date:  2020-08       Impact factor: 5.562

2.  Design and Methodology of the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD).

Authors:  Jinkook Lee; Pranali Y Khobragade; Joyita Banerjee; Sandy Chien; Marco Angrisani; Arokiasamy Perianayagam; David E Bloom; Aparajit B Dey
Journal:  J Am Geriatr Soc       Date:  2020-08       Impact factor: 5.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.